-
1
المؤلفون: Irene L.M. Reijers, Disha Rao, Judith M. Versluis, Alexander M. Menzies, Petros Dimitriadis, Michel W. Wouters, Andrew J. Spillane, Willem M.C. Klop, Annegien Broeks, Linda J.W. Bosch, Marta Lopez-Yurda, Winan J. van Houdt, Robert V. Rawson, Lindsay G. Grijpink-Ongering, Maria Gonzalez, Sten Cornelissen, Jasper Bouwman, Joyce Sanders, Elsemieke Plasmeijer, Yannick S. Elshot, Richard A. Scolyer, Bart A. van de Wiel, Daniel S. Peeper, Alexander C.J. van Akkooi, Georgina V. Long, Christian U. Blank
المساهمون: Oral and Maxillofacial Surgery, Dermatology, Graduate School, AII - Infectious diseases, AII - Inflammatory diseases, CCA - Cancer Treatment and Quality of Life
المصدر: Reijers, I L M, Rao, D, Versluis, J M, Menzies, A M, Dimitriadis, P, Wouters, M W, Spillane, A J, Klop, W M C, Broeks, A, Bosch, L J W, Lopez-Yurda, M, van Houdt, W J, Rawson, R V, Grijpink-Ongering, L G, Gonzalez, M, Cornelissen, S, Bouwman, J, Sanders, J, Plasmeijer, E, Elshot, Y S, Scolyer, R A, van de Wiel, B A, Peeper, D S, van Akkooi, A C J, Long, G V & Blank, C U 2023, ' IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma ', Journal of Experimental Medicine, vol. 220, no. 5, e20221952 . https://doi.org/10.1084/jem.20221952Test
Journal of experimental medicine, 220(5):e20221952. Rockefeller University Press
Journal of Experimental Medicine, 220(5):e20221952. Rockefeller University Pressمصطلحات موضوعية: Immunology, Immunology and Allergy
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17999c5aac89a5332bee79a05cb4e596Test
https://doi.org/10.1084/jem.20221952Test -
2
المؤلفون: Prachi Bhave, Tasnia Ahmed, Serigne N Lo, Alexander Shoushtari, Anne Zaremba, Judith M Versluis, Joanna Mangana, Michael Weichenthal, Lu Si, Thierry Lesimple, Caroline Robert, Claudia Trojanello, Alexandre Wicky, Richard Heywood, Lena Tran, Kathleen Batty, Florentia Dimitriou, Anna Stansfeld, Clara Allayous, Julia K Schwarze, Meghan J Mooradian, Oliver Klein, Inderjit Mehmi, Rachel Roberts-Thomson, Andrea Maurichi, Hui-Ling Yeoh, Adnan Khattak, Lisa Zimmer, Christian U Blank, Egle Ramelyte, Katharina C Kähler, Severine Roy, Paolo A Ascierto, Olivier Michielin, Paul C Lorigan, Douglas B Johnson, Ruth Plummer, Celeste Lebbe, Bart Neyns, Ryan Sullivan, Omid Hamid, Mario Santinami, Grant A McArthur, Andrew M Haydon, Georgina V Long, Alexander M Menzies, Matteo S Carlino
المساهمون: Clinical sciences, Laboratory of Molecular and Medical Oncology, Internal Medicine, Faculty of Medicine and Pharmacy, Medical Oncology
المصدر: Bhave, P, Ahmed, T, Lo, S N, Shoushtari, A, Zaremba, A, Versluis, J M, Mangana, J, Weichenthal, M, Si, L, Lesimple, T, Robert, C, Trojanello, C, Wicky, A, Heywood, R, Tran, L, Batty, K, Dimitriou, F, Stansfeld, A, Allayous, C, Schwarze, J K, Mooradian, M J, Klein, O, Mehmi, I, Roberts-Thomson, R, Maurichi, A, Yeoh, H L, Khattak, A, Zimmer, L, Blank, C U, Ramelyte, E, Kähler, K C, Roy, S, Ascierto, P A, Michielin, O, Lorigan, P C, Johnson, D B, Plummer, R, Lebbe, C, Neyns, B, Sullivan, R, Hamid, O, Santinami, M, McArthur, G A, Haydon, A M, Long, G V, Menzies, A M & Carlino, M S 2022, ' Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma ', Journal for ImmunoTherapy of Cancer, vol. 10, no. 7, e004668 . https://doi.org/10.1136/jitc-2022-004668Test
مصطلحات موضوعية: Pharmacology, Cancer Research, Skin Neoplasms, Manchester Cancer Research Centre, ResearchInstitutes_Networks_Beacons/mcrc, Immunology, Programmed Cell Death 1 Receptor, Medizin, Ipilimumab, oncology, Molecular Medicine, Immunology and Allergy, Humans, CTLA-4 Antigen, Immunotherapy, immunotherapy, Prospective Studies, Melanoma, Retrospective Studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92b5a9d00012b0583c371b3485e31ff2Test
https://pubmed.ncbi.nlm.nih.gov/35793872Test -
3
المؤلفون: Paolo A. Ascierto, Serigne Lo, Carlo Tondini, Richard D. Carvajal, Karijn P M Suijkerbuijk, Kerry L. Reynolds, Jessica S.W. Borgers, Jeremy Lupu, Christian U. Blank, Séverine Roy, Christian Posch, Michael Erdmann, Mario Mandalà, Ines Pires da Silva, Matteo S. Carlino, Maria Grazia Vitale, Tim Cooksley, F. Stephen Hodi, Megan H. Trager, Carola Berking, Leyre Zubiri, Laura Pala, Sharon Nahm, Dirk Schadendorf, Paola Queirolo, Alon Vaisman, Neha Papneja, Paul Lorigan, Joanna Mangana, Aljosja Rogiers, Alexander M. Menzies, Thiago Pimentel Muniz, Caroline Robert, Ryan J. Sullivan, John B. A. G. Haanen, Marcus O. Butler, Reinhard Dummer, Peter Bowling, Wilson H. Miller, Osama E. Rahma, Arielle Elkrief, Samuel D. Saibil, Chiara Tentori, Joseph M. Grimes, Michael Manos, Lisa Zimmer, Georgina V. Long, April A.N. Rose, Axel Hauschild
المصدر: Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer
Rogiers, A, Da Silva, I P, Tentori, C, Tondini, C A, Grimes, J M, Trager, M H, Nahm, S, Zubiri, L, Manos, M, Bowling, P, Elkrief, A, Papneja, N, Vitale, M G, Rose, A A N, Borgers, J S W, Roy, S, Mangana, J, Pimentel Muniz, T, Cooksley, T, Lupu, J, Vaisman, A, Saibil, S D, Butler, M O, Menzies, A M, Carlino, M S, Erdmann, M, Berking, C, Zimmer, L, Schadendorf, D, Pala, L, Queirolo, P, Posch, C, Hauschild, A, Dummer, R, Haanen, J, Blank, C U, Robert, C, Sullivan, R J, Ascierto, P A, Miller, W H, Stephen Hodi, F, Suijkerbuijk, K P M, Reynolds, K L, Rahma, O E, Lorigan, P C, Carvajal, R D, Lo, S, Mandala, M & Long, G V 2021, ' Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition ', Journal for ImmunoTherapy of Cancer, vol. 9, no. 1, e001931 . https://doi.org/10.1136/jitc-2020-001931Test
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 1 (2021)مصطلحات موضوعية: Male, 0301 basic medicine, Cancer Research, viruses, Medizin, law.invention, Cohort Studies, 0302 clinical medicine, law, Neoplasms, Immunology and Allergy, Immune Checkpoint Inhibitors, RC254-282, Cause of death, Aged, 80 and over, Clinical/Translational Cancer Immunotherapy, education.field_of_study, Manchester Cancer Research Centre, Mortality rate, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, virus diseases, Middle Aged, Intensive care unit, ddc, Oncology, 030220 oncology & carcinogenesis, Molecular Medicine, Female, immunotherapy, Adult, medicine.medical_specialty, Immunology, Population, macromolecular substances, 03 medical and health sciences, Internal medicine, Intensive care, medicine, Humans, ddc:610, Ticilimumab, Risk factor, education, Aged, Retrospective Studies, Pharmacology, SARS-CoV-2, business.industry, ResearchInstitutes_Networks_Beacons/mcrc, COVID-19, Cancer, biochemical phenomena, metabolism, and nutrition, medicine.disease, Coronavirus, 030104 developmental biology, nervous system, business
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08a1cc9e235765fb1d6543b99dc04cb3Test
http://europepmc.org/articles/PMC7817383Test -
4
المؤلفون: Christian U. Blank, Fabienne Verburg, Daniel S. Peeper, Disha Rao, Ruben Lacroix, Kathrin Renner
المصدر: Cancer immunology, immunotherapy : CII. 70(9)
مصطلحات موضوعية: Cancer Research, Nutrient depletion, Immunology, chemical and pharmacologic phenomena, Oxidative phosphorylation, Biology, medicine.disease_cause, T-Lymphocytes, Regulatory, Immunomodulation, 03 medical and health sciences, 0302 clinical medicine, Immune system, Lymphocytes, Tumor-Infiltrating, Immunity, T-Lymphocyte Subsets, Neoplasms, medicine, Tumor Microenvironment, Immunology and Allergy, Animals, Humans, Metabolomics, Hypoxia, Effector, Acidity, hemic and immune systems, Hypoxia (medical), Mitochondria, Treg, Metabolism, Oncology, Oxidative stress, Cancer cell, Cancer research, Metabolome, Disease Susceptibility, medicine.symptom, Energy Metabolism, Glycolysis, Metabolic profile, 030215 immunology
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c48eb6f74c401db2072a46b0438b446Test
https://pubmed.ncbi.nlm.nih.gov/33576875Test -
5
المؤلفون: Christian U. Blank, Daniela S. Thommen, Judith M. Versluis
المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for Immunotherapy of Cancerمصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Immunology, Context (language use), Review, Translational Research, Biomedical, 03 medical and health sciences, 0302 clinical medicine, Neoplasms, Internal medicine, Programmed cell death 1, melanoma, medicine, Humans, Immunology and Allergy, Precision Medicine, RC254-282, Pharmacology, biology, business.industry, Melanoma, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Immunotherapy, medicine.disease, Neoadjuvant Therapy, Treatment efficacy, Cancer treatment, Human tumor, Clinical trial, 030104 developmental biology, 030220 oncology & carcinogenesis, translational medical research, biology.protein, Molecular Medicine, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fe6d45de1c52a82b9d33dd6191a7069Test
https://jitc.bmj.com/content/8/2/e001352.fullTest -
6
المؤلفون: Rutger H. T. Koornstra, Christian U. Blank, Martijn H. den Brok, Sandra van Wilpe, Niven Mehra, Jan Willem B. de Groot, Winald R. Gerritsen, Jolanda De Vries
المصدر: Oncoimmunology, 9
OncoImmunology, Vol 9, Iss 1 (2020)
Oncoimmunology, 9, 1
Oncoimmunologyمصطلحات موضوعية: 0301 basic medicine, medicine.medical_treatment, Lactate dehydrogenase A, Cancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2], Immunology, Review, Rare cancers Radboud Institute for Molecular Life Sciences [Radboudumc 9], 03 medical and health sciences, chemistry.chemical_compound, Cancer development and immune defence Radboud Institute for Health Sciences [Radboudumc 2], 0302 clinical medicine, Immune system, Lactate dehydrogenase, Neoplasms, medicine, Immunology and Allergy, Humans, cancer, Glycolysis, education, RC254-282, education.field_of_study, Antitumor immunity, L-Lactate Dehydrogenase, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, lactate dehydrogenase, Immunotherapy, Hypoxia (medical), RC581-607, immune system, 030104 developmental biology, Oncology, chemistry, 030220 oncology & carcinogenesis, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], Cancer research, Tumor necrosis factor alpha, medicine.symptom, Immunologic diseases. Allergy, business, checkpoint inhibitors, Biomarkers
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8351607ccad9ce6033cbabffc9da9cedTest
http://hdl.handle.net/2066/218885Test -
7
المؤلفون: Christian U. Blank, Elisa A. Rozeman, Ines Pires da Silva, Esmée P. Hoefsmit, Kaspar Bresser, Annegien Broeks, Ton N. Schumacher, Ellen Kapiteijn, Richard A. Scolyer, Trieu-My Van, Jason Reeves, Oscar Krijgsman, Daniel S. Peeper, Steven L. C. Ketelaars, Jordan Conway, Ron M. Kerkhoven, Jacqueline E. van der Wal, Georgina V. Long, Sarah Warren, Petros Dimitriadis, Pia Kvistborg
المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, 8(2). BMJ PUBLISHING GROUP
Journal for ImmunoTherapy of Cancerمصطلحات موضوعية: Male, Uveal Neoplasms, 0301 basic medicine, Cancer Research, Skin Neoplasms, T cell, medicine.medical_treatment, Immunology, 03 medical and health sciences, 0302 clinical medicine, Antigen, melanoma, tumor microenvironment, Humans, Immunology and Allergy, Medicine, RC254-282, Retrospective Studies, Clinical/Translational Cancer Immunotherapy, Pharmacology, Tumor microenvironment, business.industry, Melanoma, Liver Neoplasms, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Immunotherapy, medicine.disease, immunity, Immune checkpoint, 030104 developmental biology, medicine.anatomical_structure, Oncology, 030220 oncology & carcinogenesis, translational medical research, Cutaneous melanoma, Cancer research, Molecular Medicine, Immunohistochemistry, Female, immunotherapy, business
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::104977900a329903a1fe0ba46dec9971Test
https://doi.org/10.1136/jitc-2020-001501Test -
8
المؤلفون: Christian U. Blank, Mark J. Smyth, Jing Liu, Stacey Allen, Jake S. O’Donnell, Elisa A. Rozeman, Lorenzo F. Fanchi, Michele W.L. Teng
المصدر: OncoImmunology, Vol 8, Iss 2 (2019)
مصطلحات موضوعية: 0301 basic medicine, lcsh:Immunologic diseases. Allergy, medicine.medical_treatment, Immunology, Ipilimumab, lcsh:RC254-282, surgery, 03 medical and health sciences, 0302 clinical medicine, Cancer immunotherapy, medicine, Immunology and Allergy, mouse models, metastases, neoadjuvant immunotherapy, business.industry, Cancer, Immunotherapy, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Primary tumor, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, batf3+ dc, Cancer research, type i ifn, Nivolumab, business, lcsh:RC581-607, Adjuvant, CD8, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55bd38c9d0ab1c457c7b7f54bd980f0aTest
https://doaj.org/article/9cb1a065726841ffad39b3e29814631fTest -
9
المؤلفون: Rudolf S N Fehrmann, Rozemarijn S. van Rijn, Thijs T Wind, Elisabeth G.E. de Vries, Marcel A. T. M. van Vugt, Jacco J de Haan, Geke A. P. Hospers, Dirk-Jan Reijngoud, John B. A. G. Haanen, Christian U. Blank, Mathilde Jalving
المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Damage and Repair in Cancer Development and Cancer Treatment (DARE), Targeted Gynaecologic Oncology (TARGON)
المصدر: Oncoimmunology
OncoImmunology, Vol 8, Iss 3 (2019)
OncoImmunology, 8(3):1558664. Taylor & Francis Groupمصطلحات موضوعية: 0301 basic medicine, Oncology, lcsh:Immunologic diseases. Allergy, medicine.medical_specialty, CDK4, Immunology, Biology, METABOLISM, lcsh:RC254-282, Subclass, THERAPIES, SUBTYPES, Biological pathway, 03 medical and health sciences, 0302 clinical medicine, PGC1-ALPHA, Internal medicine, Gene expression, medicine, Immunology and Allergy, METASTATIC MELANOMA, Clinical significance, CELL, Gene, Original Research, molecular classification, anti-PD-1 therapy, consensus clustering, Cancer, INHIBITOR, Cell cycle, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, CANCER, 030104 developmental biology, 030220 oncology & carcinogenesis, Cutaneous melanoma, SURVIVAL, gene expression, pooled analysis, lcsh:RC581-607
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0535723b6ce51a28a3f753ccde35a211Test
http://europepmc.org/articles/PMC6350693Test -
10
المؤلفون: Alfonsus J. M. van den Eertwegh, Mathilde Jalving, Geke A. P. Hospers, Christian U. Blank, Ellen Kapiteijn, Jan Willem de Groot, Rutger H. T. Koornstra, Thijs T Wind, C. Bisschop
المساهمون: Targeted Gynaecologic Oncology (TARGON), Medical oncology, CCA - Cancer biology and immunology, AII - Cancer immunology
المصدر: Journal of Immunotherapy, 42(6), 208-214. LIPPINCOTT WILLIAMS & WILKINS
Bisschop, C, Wind, T T, Blank, C U, Koornstra, R H T, Kapiteijn, E, van den Eertwegh, A J M, de Groot, J W B, Jalving, M & Hospers, G A P 2019, ' Association between Pembrolizumab-related Adverse Events and Treatment Outcome in Advanced Melanoma: Results from the Dutch Expanded Access Program ', Journal of Immunotherapy, vol. 42, no. 6, pp. 208-214 . https://doi.org/10.1097/CJI.0000000000000271Test
Journal of Immunotherapy, 42(6), 208-214. Lippincott Williams and Wilkins
Journal of Immunotherapy (1997), 42, 6, pp. 208-214
Journal of Immunotherapy (1997), 42, 208-214مصطلحات موضوعية: Male, 0301 basic medicine, Cancer Research, medicine.medical_specialty, disease control, overall survival, Immunology, IMMUNE, Pembrolizumab, Antibodies, Monoclonal, Humanized, Lower risk, Cancer development and immune defence Radboud Institute for Health Sciences [Radboudumc 2], 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Internal medicine, ANTI-PD-1, melanoma, Humans, Immunology and Allergy, Medicine, Progression-free survival, Neoplasm Staging, Netherlands, Proportional Hazards Models, Pharmacology, Clinical Trials as Topic, business.industry, Proportional hazards model, IPILIMUMAB, Hazard ratio, NIVOLUMAB, Odds ratio, EFFICACY, Confidence interval, adverse events, Treatment Outcome, 030104 developmental biology, 030220 oncology & carcinogenesis, Expanded access, SAFETY, Female, pembrolizumab, business, progression-free survival, Follow-Up Studies
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8025fd41c60e26f6dca093e0409d88b3Test
https://doi.org/10.1097/CJI.0000000000000271Test